HEXIM2
Protein HEXIM2
Also known as: FLJ32384, HEXI2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96MH2
- Gene
- HEXIM2
- Ensembl
- ENSG00000168517
- Chromosome
- 17
- Canonical length
- 286 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear speckles
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
This gene encodes a member of the HEXIM family of proteins. This protein is a component of the 7SK small nuclear ribonucleoprotein. This protein has been found to negatively regulate the kinase activity of the cyclin-dependent kinase P-TEFb, which phosphorylates multiple target proteins to promote transcriptional elongation. This gene is located approximately 7 kb downstream from related family member HEXIM1 on chromosome 17. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
Canonical amino-acid sequenceUniProt
286 residues, UniProt reviewed canonical sequence.
>Q96MH2|HEXIM2
1 MMATPNQTAC NAESPVALEE AKTSGAPGSP QTPPERHDSG GSLPLTPRME SHSEDEDLAG
61 AVGGLGWNSR SPRTQSPGGC SAEAVLARKK HRRRPSKRKR HWRPYLELSW AEKQQRDERQ
121 SQRASRVREE MFAKGQPVAP YNTTQFLMND RDPEEPNLDV PHGISHPGSS GESEAGDSDG
181 RGRAHGEFQR KDFSETYERF HTESLQGRSK QELVRDYLEL EKRLSQAEEE TRRLQQLQAC
241 TGQQSCRQVE ELAAEVQRLR TENQRLRQEN QMWNREGCRC DEEPGTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HEXIM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 44 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 44 nTPM
- testis: 32 nTPM
- liver: 12 nTPM
- tongue: 10 nTPM
- kidney: 8.9 nTPM
- basal ganglia: 8.7 nTPM
Single-cell type
- late spermatids: 426 nCPM
- late primary spermatocytes: 169 nCPM
- cardiomyocytes: 164 nCPM
- early spermatids: 132 nCPM
- platelets: 124 nCPM
- oocytes: 78 nCPM
Immune cell
- plasmacytoid DC: 11 nTPM
- total PBMC: 11 nTPM
- classical monocyte: 9.4 nTPM
- memory B-cell: 8.9 nTPM
- myeloid DC: 8.3 nTPM
- eosinophil: 8.2 nTPM
Brain region
- choroid plexus: 23 nTPM
- cerebellum: 19 nTPM
- thalamus: 16 nTPM
- medulla oblongata: 16 nTPM
- amygdala: 16 nTPM
- spinal cord: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 0.09
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of DNA-templated transcription
- negative regulation of G2/M transition of mitotic cell cycle
- negative regulation of transcription by RNA polymerase II
Molecular functions
- 7SK snRNA binding
- cyclin-dependent protein serine/threonine kinase inhibitor activity
- identical protein binding
- snRNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HEXIM2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HEXIM2 as an antibody target. Whether an autoantibody or antibody against HEXIM2 could matter depends on whether native HEXIM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HEXIM2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HEXIM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...